Preliminary Effectiveness of Enhanced Text Message + Incentives

Part of paid clinical trials in Kansas City, Kansas.

Sponsor
University of Kansas Medical Center
Study ID
NCT07420621
Status
Recruiting
Apply to this trial

Conditions

  • Pregnancy
  • Smoking Cessation

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Text Messages — BEHAVIORAL
    Intervention Component - Text messages (SmokeFreeTXT library with pregnancy related messages) participants will receive scheduled messages to support quitting and prevent relapse.
  • Incentives — BEHAVIORAL
    Incentives for abstinence - Weeks 1-4; 8; 12: Twice daily CO assessments with verification sent via text-message. Participants will receive daily incentives ranging each day of smoking abstinence.

Study Details

This study is a preliminary evaluation of a smoking cessation intervention designed for pregnant women that combines text message support and financial incentives. The aims of this study are to determine the preliminary feasibility and acceptability of text message + incentives (intervention) vs. text message only (control).

Key Dates

Start date
Apr 9, 2026
Status verified
Apr 2026
Primary completion
Jun 1, 2026
Completion
Aug 1, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Text Messaging + Incentives
    Participants in this arm will receive a combination of text messages designed to support smoking cessation and escalating financial incentives contingent on biochemically-verified smoking abstinence (exhaled carbon monoxide).
  • Active Comparator: Text Messaging Only
    Participants in this arm will receive the same text messaging program as in Arm 1, but without the financial incentives contingent on abstinence.

Primary Outcome Measure

Feasibility of Intervention [ Time Frame: 4 weeks post-randomization ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Kansas Medical CenterKansas CityKansas66160
Taneisha Scheuermann, PhD
[email protected]
913-588-2641
Taneisha Scheuermann, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Kansas City, KS

By research site
University of Kansas Medical Center· Kansas City, KS

Related Studies